A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma
AuthID
P-003-0Y3
P-003-0Y3
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service